Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.

The ability of apolipoprotein E (apoE) to bind to cell-surface glycosaminoglycans (GAGs) is important for lipoprotein remnant catabolism. Using surface plasmon resonance, we previously showed that the binding of apoE to heparin is a two-step process; the initial binding involves fast electrostatic interaction, followed by a slower hydrophobic interaction. Here we examined the contributions of the N- and C-terminal domains to each step of the binding of apoE isoforms to heparan sulfate (HS) and dermatan sulfate (DS). ApoE3 bound to less sulfated HS and DS with a decreased favorable free energy of binding in the first step compared to heparin, indicating that the degree of sulfation has a major effect on the electrostatic interaction of GAGs with apoE. Mutation of a key Lys residue in the N-terminal heparin binding site of apoE significantly affected this electrostatic interaction. Progressive truncation of the C-terminal alpha-helical regions which favors the monomeric form of apoE3 greatly weakened the ability of apoE3 to bind to HS, with a much reduced favorable free energy of binding of the first step, suggesting that the C-terminal domain contributes to the GAG binding of apoE by the oligomerization effect. In agreement with this, dimerization of the apoE3 N-terminal fragment via disulfide linkage restored the electrostatic interaction of apoE with HS. Significantly, apoE4 exhibited much stronger binding to HS and DS than apoE2 or apoE3 in both lipid-free and lipidated states, perhaps resulting from enhanced electrostatic interaction through the N-terminal domain. This isoform difference in GAG binding of apoE may be physiologically significant such as in the retention of apoE-containing lipoproteins in the arterial wall.

[1]  H. Saito,et al.  Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. , 2008, Biochemistry.

[2]  J. Seelig,et al.  Melittin interaction with sulfated cell surface sugars. , 2008, Biochemistry.

[3]  Radiya M. Sojitrawala,et al.  A monomeric, biologically active, full-length human apolipoprotein E. , 2007, Biochemistry.

[4]  R. Mahley,et al.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. , 2007, The Journal of clinical investigation.

[5]  J. Esko,et al.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. , 2007, The Journal of clinical investigation.

[6]  K. Weisgraber,et al.  Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.

[7]  H. Saito,et al.  Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. , 2006, Biochemistry.

[8]  J. Seelig,et al.  Structural and thermodynamic aspects of the interaction between heparan sulfate and analogues of melittin. , 2006, Biochemistry.

[9]  A. Rapp,et al.  Role of chondroitin sulphate in the uptake of β‐VLDL by brain cells , 2005 .

[10]  P. Axelsen,et al.  Structural analysis of lipoprotein E particles. , 2005, Biochemistry.

[11]  K. Williams,et al.  Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. , 2005, Diabetes.

[12]  Hiroyuki Saito,et al.  Two-step Mechanism of Binding of Apolipoprotein E to Heparin , 2005, Journal of Biological Chemistry.

[13]  J. Borén,et al.  Mechanism of lipoprotein retention by the extracellular matrix , 2004, Current opinion in lipidology.

[14]  A. Chait,et al.  Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice , 2004, Circulation.

[15]  K. Weisgraber,et al.  Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.

[16]  S. Wehrli,et al.  Characterization of the Heparin Binding Sites in Human Apolipoprotein E* , 2003, The Journal of Biological Chemistry.

[17]  M. Togo,et al.  Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[18]  R. E. Pitas,et al.  Evidence for differential effects of apoE3 and apoE4 on HDL metabolism Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200172-JLR200 , 2002, Journal of Lipid Research.

[19]  A. Chait,et al.  Apolipoprotein E Mediates the Retention of High-Density Lipoproteins by Mouse Carotid Arteries and Cultured Arterial Smooth Muscle Cell Extracellular Matrices , 2002, Circulation research.

[20]  R. Linhardt,et al.  Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. , 2002, Biochemistry.

[21]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[22]  K. Weisgraber,et al.  Lipid Binding-induced Conformational Change in Human Apolipoprotein E , 2001, The Journal of Biological Chemistry.

[23]  Ishan Capila,et al.  New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E* , 2001, The Journal of Biological Chemistry.

[24]  J. Moses,et al.  Glycosaminoglycan-lipoprotein interaction , 2001, Glycoconjugate Journal.

[25]  O. Klezovitch,et al.  Domains of apolipoprotein E involved in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and anti-atherogenic properties of this apolipoprotein. , 2001, Trends in cardiovascular medicine.

[26]  D. Hui,et al.  Apolipoprotein E Receptor Binding VersusHeparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation* , 2001, The Journal of Biological Chemistry.

[27]  Z. Huang,et al.  Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE. , 2001, Journal of lipid research.

[28]  M C Phillips,et al.  Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. , 2001, Journal of lipid research.

[29]  B. Rupp,et al.  Interaction of the N-terminal domain of apolipoprotein E4 with heparin. , 2001, Biochemistry.

[30]  Suzanne Wehrli,et al.  Effects of Lipid Interaction on the Lysine Microenvironments in Apolipoprotein E* , 2000, The Journal of Biological Chemistry.

[31]  O. Klezovitch,et al.  Structural Determinants in the C-terminal Domain of Apolipoprotein E Mediating Binding to the Protein Core of Human Aortic Biglycan* , 2000, The Journal of Biological Chemistry.

[32]  Yan Xu,et al.  Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. , 2000, The Journal of clinical investigation.

[33]  R. Colman,et al.  Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. , 2000, Biochemistry.

[34]  M. Germann,et al.  Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans* , 2000, The Journal of Biological Chemistry.

[35]  S. Smith‐Gill,et al.  Experimental design for analysis of complex kinetics using surface plasmon resonance. , 2000, Methods.

[36]  G. Siest,et al.  Kinetics of apolipoprotein E isoforms‐binding to the major glycosaminoglycans of the extracellular matrix , 1999, FEBS letters.

[37]  Y. Marcel,et al.  ApoE of the HepG2 cell surface includes a major pool associated with chondroitin sulfate proteoglycans. , 1999, Biochemistry.

[38]  R. Mahley,et al.  Differential Cellular Accumulation/Retention of Apolipoprotein E Mediated by Cell Surface Heparan Sulfate Proteoglycans , 1998, The Journal of Biological Chemistry.

[39]  J. Weiler,et al.  Glycosaminoglycan‐protein interactions: definition of consensus sites in glycosaminoglycan binding proteins , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  A. Cooper Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.

[41]  M. Salmivirta,et al.  Heparan sulfate : a piece of information , 2004 .

[42]  P. Gaffney,et al.  Interaction of heparin with fibrinogen using surface plasmon resonance technology: investigation of heparin binding site on fibrinogen. , 1996, Thrombosis research.

[43]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[45]  K. Weisgraber,et al.  Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. , 1993, The Journal of biological chemistry.

[46]  D A Agard,et al.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.

[47]  K. Weisgraber,et al.  Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. , 1988, The Journal of biological chemistry.

[48]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[49]  R. Mahley,et al.  Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. , 1986, The Journal of biological chemistry.

[50]  J. Sparrow,et al.  Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. , 1986, Biochemical and biophysical research communications.

[51]  B. Sörbo,et al.  Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine. , 1980, Clinical chemistry.

[52]  A. Gotto,et al.  Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. , 1973, Biochemistry.

[53]  A. Rapp,et al.  Role of chondroitin sulphate in the uptake of beta-VLDL by brain cells. , 2005, European Journal of Neuroscience.

[54]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[55]  R. Mahley,et al.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.

[56]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.

[57]  D. Myszka,et al.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.

[58]  K. Weisgraber Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.